MedPage Today reports Sens. Charles Grassley (R-IA) and Herb Kohl (D-WI) “have urged the Centers for Medicare and Medicaid Services (CMS) to take a closer look at potential over-prescribing of atypical antipsychotics to nursing home residents.” In a letter to CMS administrator Donald Berwick, MD, Grassley and Kohl request “that CMS investigate what role pharmacy benefit managers — who manage prescription drug coverage for Medicare beneficiaries living in nursing homes — play in fueling the possible overuse of atypical antipsychotics in elderly people in long-term-care facilities.” MedPage Today notes, “The letter is a follow-up to one the senators sent in May after the release of the OIG report, which the senators themselves requested.”

From the American Association for Justice news release.